{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:11:40Z","timestamp":1779923500685,"version":"3.53.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T00:00:00Z","timestamp":1479686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s13730-016-0244-z","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T11:21:49Z","timestamp":1479727309000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressant"],"prefix":"10.1007","volume":"6","author":[{"given":"Fumiaki","family":"Obata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taichi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taizo","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Minato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiya","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motokazu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideharu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,21]]},"reference":[{"key":"244_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","volume":"345","author":"G Lauer","year":"2001","unstructured":"Lauer G, Walker B. Hepatitis C virus infection. N Engl J Med. 2001;345:41\u201352.","journal-title":"N Engl J Med"},{"key":"244_CR2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0272-6386(89)80143-X","volume":"14","author":"JV Donadio","year":"1989","unstructured":"Donadio JV, Offord PK. Reassessment of treatment results in\u00a0membranoproliferative glomerulonephritis, with emphasis on life-table\u00a0analysis. Am J Kidney Dis. 1989;14:445\u201351.","journal-title":"Am J Kidney Dis"},{"key":"244_CR3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-125-9-199611010-00030","volume":"125","author":"E Lopes","year":"1996","unstructured":"Lopes E, Lopes LV, Silva AE. Mixedcryoglobulinemia and\u00a0membranoproliferative glomerulonephritis associated with hepatitis C\u00a0virus infection. Ann Intern Med. 1996;125:781\u20132.","journal-title":"Ann Intern Med"},{"key":"244_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhep.2014.04.004","volume":"61","author":"N Hayashi","year":"2014","unstructured":"Hayashi N, Izumi N, Kumada H, Okanoue T, Tsubouchi H, Yatsuhashi H, Kato M, Ki R, Komada Y, Seto C, Goto S. Simeprevir with peginterferon\/ribavirin for treatment-naive hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial. J Hepatol. 2014;61:219\u201327.","journal-title":"J Hepatol"},{"key":"244_CR5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1053\/j.gastro.2013.10.058","volume":"146","author":"S Zeuzem","year":"2014","unstructured":"Zeuzem S, Berg T, Gane E, Ferenci P, Foster GR, Fried MW, Hezode C, Hirschfield GM, Jacobson I, Nikitin I, Pockros PJ, Poordad F, Scott J, Lenz O, Peeters M, Sekar V, De Smedt G, Sinha R, Beumont Mauviel M. Simeprevir increases rate of sustained virologic response among\u00a0treatment-experienced patients with HCV genotype-1 Infection: a phase\u00a0IIb trial. Gastroenterology. 2014;146:430\u201341.","journal-title":"Gastroenterology"},{"key":"244_CR6","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","volume":"59","author":"H Kumada","year":"2014","unstructured":"Kumada H, Suzuki Y, Ikeda K, Toyota J, Karino Y, Chayama K, Kawakami Y, Ido A, Yamamoto K, Takaguchi K, Izumi N, Koike K, Takehara T, Kawada N, Sata M, Miyagoshi H, Eley T, McPhee F, Damokosh A, Ishikawa H, Hughes E. Daclatasvir plus asunaprevir\u00a0for chronic HCV genotype 1b infection. Hepatology. 2014;59:2083\u201391.","journal-title":"Hepatology"},{"issue":"5","key":"244_CR7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2169\/naika.100.1289","volume":"100","author":"Seiji Kishi","year":"2011","unstructured":"Kishi Seiji, Doi Toshio. Paraproteinemia: 3. Cryoglobulinemia. Nihon Naika Gakkai Zasshi. 2011;100(5):1289\u201395.","journal-title":"Nihon Naika Gakkai Zasshi"},{"issue":"7","key":"244_CR8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","volume":"45","author":"L Quartuccio","year":"2006","unstructured":"Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology. 2006;45(7):842\u20136.","journal-title":"Rheumatology"},{"issue":"3","key":"244_CR9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","volume":"116","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Copp\u00e9r\u00e9 B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P. Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood. 2010;116(3):326\u201334.","journal-title":"Blood"},{"issue":"11","key":"244_CR10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","volume":"330","author":"R Misiani","year":"1994","unstructured":"Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Luigi Sironi P, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994;330(11):751\u20136.","journal-title":"N Engl J Med"},{"issue":"6","key":"244_CR11","first-page":"933","volume":"29","author":"C Mazzaro","year":"2011","unstructured":"Mazzaro C, Monti G, Saccardo F, Zignego AL, Ferri C, De Vita S, Gabrielli A, Lenzi M, Donada C, Galli M, Pietrogrande M, Pozzato G. Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. Clin Exp Rheumatol. 2011;29(6):933\u201341.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"244_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","volume":"10","author":"M Pietrogrande","year":"2011","unstructured":"Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G, Galli M. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev. 2011;10(8):444\u201354.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"244_CR13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1478-3231.2010.02283.x","volume":"30","author":"T Asselah","year":"2010","unstructured":"Asselah T, Estrabaud E, Bieche I, Lapalus M, De Muynck S, Vidaud M, Saadoun D, Soumelis V, Marcellin P. Hepatitis C: viral and host factors associated with non-response to pegylated\u00a0interferon plus ribavirin. Liver Int. 2010;30(9):1259\u201369.","journal-title":"Liver Int"},{"issue":"3","key":"244_CR14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2004.11.034","volume":"42","author":"G Kaplanski","year":"2005","unstructured":"Kaplanski G, Maisonobe T, Marin V, Gr\u00e8s S, Robitail S, Farnarier C, Harl\u00e9 JR, Piette JC, Cacoub P. Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia. J Hepatol. 2005;42(3):334\u201340.","journal-title":"J Hepatol"},{"issue":"14","key":"244_CR15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2169\/internalmedicine.49.3596","volume":"49","author":"H Yamabe","year":"2010","unstructured":"Yamabe H, Nakamura N, Shimada M, Murakami R, Fujita T, Shimaya Y, Kitajima M, Urushizaka M. Clinicopathological study on hepatitis C virus-associated glomerulonephritis without hepatitis C virus in the blood. Intern Med. 2010;49(14):1321\u20133.","journal-title":"Intern Med"},{"issue":"7","key":"244_CR16","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/ndt\/gfm205","volume":"22","author":"RS Barsoum","year":"2007","unstructured":"Barsoum RS. Hepatitis C virus: from entry to renal injury\u2013facts and potentials. Nephrol Dial Transplant. 2007;22(7):1840\u20138.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"244_CR17","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.4049\/jimmunol.169.8.4644","volume":"169","author":"S Kikuchi","year":"2002","unstructured":"Kikuchi S, Pastore Y, Fossati-Jimack L, Kuroki A, Yoshida H, Fulpius T, Araki K, Takahashi S, Lemoine R, Reininger L, Izui S. A transgenic mouse model of autoimmune glomerulonephritis and necrotizing arteritis associated with\u00a0cryoglobulinemia. J Immunol. 2002;169(8):4644\u201350.","journal-title":"J Immunol"},{"key":"244_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.gastro.2014.04.045","volume":"147","author":"P Andreone","year":"2014","unstructured":"Andreone P, Colombo MG, Enejosa JV, Koksal I, Ferenci P, Maieron A, M\u00fcllhaupt B, Horsmans Y, Weiland O, Reesink HW, Rodrigues L Jr, Hu YB, Podsadecki T, Bernstein B. ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100%\u00a0sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection. Gastroenterology. 2014;147:359\u201365.","journal-title":"Gastroenterology"},{"key":"244_CR19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hep.24724","volume":"55","author":"K Chayama","year":"2012","unstructured":"Chayama K, Takahashi S, Toyota J, Karino Y, Ikeda K, Ishikawa H, Watanabe H, McPhee F, Hughes E, Kumada H. Dual therapy with the nonstructural protein 5A inhibitor,\u00a0daclatasvir, and the nonstructural protein 3 protease inhibitor,\u00a0asunaprevir, in hepatitis C virus genotype 1b-infected null responders. Hepatology. 2012;55:742\u20138.","journal-title":"Hepatology"},{"key":"244_CR20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2012.11.012","volume":"58","author":"Y Karino","year":"2012","unstructured":"Karino Y, Toyota J, Ikeda K, Suzuki F, Chayama K, Kawakami Y, Ishikawa H, Watanabe H, Hernandez D, Yu F, McPhee F, Kumada H. Characterization of virologic escape in hepatitis C virus genotype\u00a01b patients treated with the direct-acting antivirals daclatasvir and\u00a0asunaprevir. J Hepatol. 2012;58:646\u201354.","journal-title":"J Hepatol"},{"key":"244_CR21","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","volume":"368","author":"E Lawitz","year":"2013","unstructured":"Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, Schultz M, Davis MN, Kayali Z, Reddy KR, Jacobson IM, Kowdley KV, Nyberg L, Subramanian, Hyland RH, Arterburn S, Jiang D, McNally J, Brainard D, Symonds WT, McHutchison JG, Sheikh AM, Younossi Z, Gane EJ. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013;368:1878\u201387.","journal-title":"N Engl J Med."},{"key":"244_CR22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2012.09.037","volume":"58","author":"Y Suzuki","year":"2012","unstructured":"Suzuki Y, Ikeda K, Suzuki F, Toyota J, Karino Y, Chayama K, Kawakami Y, Ishikawa H, Watanabe H, Hu W, Eley T, McPhee F, Hughes E, Kumada H. Dual oral therapy with daclatasvir and asunaprevir for patients with\u00a0HCV genotype 1b infection and limited treatment options. J Hepatol. 2012;58:655\u201362.","journal-title":"J Hepatol"},{"key":"244_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206180","author":"G Stine","year":"2014","unstructured":"Stine G, Cornella S, Shah NL. Treatment of chronic hepatitis C\u00a0complicated by mixed cryoglobulinemia with new protease inhibitor, sofosbuvir. Ann Rheum Dis. 2014;. doi:\n                        10.1136\/annrheumdis-2014-206180\n                        \n                    .","journal-title":"Ann Rheum Dis"},{"key":"244_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/816424","author":"T Urraro","year":"2015","unstructured":"Urraro T, Gragnani L, Piluso A, Fabbrizzi A, Monti M, Fognani E, Boldrini B, Ranieri J, Zignego AL. Combined treatment with antiviral therapy and rituximab\u00a0in patients with mixed cryoglobulinemia: review of the literature and\u00a0report of a case using direct antiviral agents-based antihepatitis C\u00a0virus therapy. Case Rep Immunol. 2015;. doi:\n                        10.1155\/2015\/816424\n                        \n                    .","journal-title":"Case Rep Immunol"},{"key":"244_CR25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/00325481.2015.1021660","volume":"127","author":"SL Cornella","year":"2015","unstructured":"Cornella SL, Stine JG, Kelly V, Caldwell SH, Shah NL. Persistence\u00a0of mixed cryoglobulinemia despite cure of hepatitis C with new oral\u00a0antiviral therapy including direct- acting antiviral sofosbuvir: a case\u00a0series. Postgrad Med. 2015;127:413\u20137.","journal-title":"Postgrad Med"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-016-0244-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-016-0244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,20]],"date-time":"2017-05-20T06:43:58Z","timestamp":1495262638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-016-0244-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,21]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1007\/s13730-016-0244-z","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,21]]}}}